Exelixis
EXEL
EXEL
346 hedge funds and large institutions have $5.08B invested in Exelixis in 2019 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 136 increasing their positions, 110 reducing their positions, and 66 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
8% less funds holding
Funds holding: 377 → 346 (-31)
11% less capital invested
Capital invested by funds: $5.69B → $5.08B (-$616M)
36% less first-time investments, than exits
New positions opened: 42 | Existing positions closed: 66
Holders
346
Holding in Top 10
3
Calls
$86.7M
Puts
$57.5M
Top Buyers
| 1 | +$83.1M | |
| 2 | +$79.9M | |
| 3 | +$47.3M | |
| 4 |
O
OrbiMed
New York
|
+$23.7M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$22.5M |
Top Sellers
| 1 | -$89.8M | |
| 2 | -$46.2M | |
| 3 | -$45.2M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$42.7M |
| 5 |
Goldman Sachs
New York
|
-$36.9M |